Could bright glasses beat brain fog? new study tests light therapy in young cancer survivors
NCT ID NCT05340881
First seen Jun 26, 2026 ยท Last updated Jun 26, 2026
Summary
This study tests whether wearing special glasses that emit bright light can help reduce fatigue and improve thinking speed and attention in children and teens who have been treated for a brain tumor. The study will include 40 survivors and compare the bright light glasses to dim light (placebo) glasses over 6 weeks. The main goal is to see if this approach is practical and acceptable, not yet to prove it works.
What this could mean
Our plain-language read of the trial. This is informational only โ not medical advice or a prediction.
- Active substance
- bright light exposure
- What this could lead to
- If it works, this could point toward a simple, non-drug way to help brain tumor survivors feel less tired and think more clearly.
- What could go wrong
- This is a very small, early pilot study (40 people) testing feasibility, not effectiveness. The results may not apply to all survivors, and the light therapy may cause side effects like eye strain or headache.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BRAIN TUMOR are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Texas Children's Hospital
RECRUITINGHouston, Texas, 77030, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can trained immune cells outsmart brain tumors?
- Digital tests may offer a new way to track brain health in tumor patients
- Mapping the hidden toll of brain radiation on young minds
- Scientists create detailed brain maps to protect language during surgery
- Could a cancer drug shrink recurrent brain tumors?
- Engineered immune cells target deadly brain tumors in children